Triple

T6003749
Position Surface form Disambiguated ID Type / Status
Subject Loxo Oncology E133655 entity
Predicate regulatoryAgencyApproval P16099 FINISHED
Object U.S. Food and Drug Administration E13297 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [Loxo Oncology, regulatoryAgencyApproval, U.S. Food and Drug Administration]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration
Context triple: [Loxo Oncology, regulatoryAgencyApproval, U.S. Food and Drug Administration]
  • A. Food and Drug Administration chosen
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • E. FDA CFSAN
    FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: regulatoryAgencyApproval
Context triple: [Loxo Oncology, regulatoryAgencyApproval, U.S. Food and Drug Administration]
  • A. hasRegulatoryApproval
    Indicates that an entity has received formal authorization or clearance from a relevant regulatory authority to operate, be sold, or be used in a specified context.
  • B. regulatingAgency chosen
    Indicates that one entity serves as the official authority responsible for overseeing, controlling, or enforcing rules and standards on another entity or activity.
  • C. FDAApprovalType
    Indicates the specific regulatory pathway or category under which a product has been approved by the U.S. Food and Drug Administration.
  • D. regulatoryOutcome
    Indicates the result or consequence of a regulatory process, such as approval, rejection, modification, or other formal decision made by a regulatory authority regarding an entity or action.
  • E. regulatoryApprovalYear
    Indicates the calendar year in which an official regulatory body granted approval for the referenced item, action, or entity.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c00872444c8190bfaf1739dcec765c completed March 22, 2026, 3:19 p.m.
NER Named-entity recognition batch_69c04f0f63148190826198281dce3713 completed March 22, 2026, 8:20 p.m.
NED1 Entity disambiguation (via context triple) batch_69c1088f5c84819094e4696c24c4dd79 completed March 23, 2026, 9:31 a.m.
PD Predicate disambiguation batch_69c049e3316c819087ea635fa7ee8472 completed March 22, 2026, 7:58 p.m.
Created at: March 22, 2026, 4:06 p.m.